CAN2401. Welcome Remarks | Keynote - Navigating the Impacts of Cannabis Rescheduling

This session will delve into the multifaceted implications of the potential reclassification of cannabis from Schedule I to Schedule III under the Controlled Substances Act and its effects on various sectors of the industry. Led by renowned industry experts, attendees will gain insights into the shifting landscape of capital markets, taxation policies, and legislative developments. From understanding the market dynamics to anticipating legislative changes and exploring the challenges and opportunities ahead, this session offers a comprehensive analysis of the rescheduling's ramifications.

Learning Objectives:

• Evaluate the evolving landscape of cannabis capital markets, including the impact of rescheduling on investment trends, M&A activity, and capital deployment strategies.
• Assess the interplay between legislative efforts, taxation policies, and industry dynamics in the wake of potential cannabis rescheduling.